Genetic CRC risk likely mediated by differential adenoma risk

January 10, 2013
Genetic CRC risk likely mediated by differential adenoma risk
Much of the genetic risk for colorectal cancer in the general population is mediated by differential adenoma risk, according to research published in the January issue of Gastroenterology.

(HealthDay)—Much of the genetic risk for colorectal cancer (CRC) in the general population is mediated by differential adenoma risk, according to research published in the January issue of Gastroenterology.

Luis G. Carvajal-Carmona, Ph.D., from the University of Oxford in the United Kingdom, and colleagues analyzed genotype data from 1,755 adenoma cases and 3,976 controls with no colorectal disease for 18 CRC single-nucleotide polymorphisms (SNPs).

The researchers found that eight of 18 known CRC-associated SNPs (rs10936599, rs6983267, rs10795668, rs3802842, rs4444235, rs1957636, rs4939827, and rs961253) were over-represented in CRC-free patients with adenomas, compared with controls. There was no significant association with adenoma risk with the other CRC-associated SNPs (rs6691170, rs6687758, rs16892766, rs7136702, rs11169552, rs4779584, rs9929218, rs10411210, rs4813802, and rs4925386).

" to CRC in the general population is likely to be mediated in part by predisposition to ," the authors write. "In principle, especially if further studies can assign SNPs as adenoma-predisposing, carcinoma-predisposing, or both, such variation could be used to modulate population-based CRC-prevention measures, in a way analogous to the different
methods of prophylaxis used for familial adenomatous polyposis and Lynch syndrome."

Pfizer and Merck both contributed funding to this research.

Explore further: Reduced efficacy for CRC screenings done by non-GI docs

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Reduced efficacy for CRC screenings done by non-GI docs

June 22, 2012
(HealthDay) -- Having interval colorectal cancer (CRC) colonoscopy screenings performed by nongastroenterologists compared with gastroenterologists (GIs) results in a noticeable reduction in the long-term CRC prevention rate, ...

Study says screening accounts for much of black/white disparity in colorectal cancer

May 3, 2012
A new study finds differences in screening account for more than 40 percent of the disparity in colorectal cancer incidence and nearly 20 percent of colorectal cancer mortality between blacks and whites. Differences in stage-specific ...

Post-polyp detection, CRC risk ID'd by colonoscopy factors

August 21, 2012
(HealthDay) -- In the community setting, after colonoscopic polyp detection, colonoscopy-related factors such as incomplete polyp removal and lack of surveillance colonoscopies are more important than polyp characteristics ...

Obesity may modify the association between alcohol consumption and the risk of colorectal cancer

February 23, 2012
A case-control study from Newfoundland/Labrador has reported that greater alcohol intake may increase the risk of colorectal cancer (CRC) among obese subjects, but not among non-obese subjects. This is not a particularly ...

Study examines whether age for initial screening colonoscopy should be different for men, women

September 27, 2011
An analysis of results of more than 40,000 screening colonoscopies finds that men have a higher rate of advanced tumors compared to women in all age groups examined, suggesting that the age that individuals should undergo ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.